Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival

Why this matters: new research or scientific developments with potential real-world impact.

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn't be done. In a major clinical trial, the treatment nearly